Dr. Doug Fisher joined InterWest's healthcare team in 2009, focusing on biopharmaceutical, diagnostic, and medical device investments.
He is a board member of Cardiac Dimensions, Gynesonics, Obalon Therapeutics, PMV Pharma, QuatRx, Sera Prognostics and USDS. Doug also is actively involved in InterWest's investments in Integrated Diagnostics and Invuity.
Prior to joining InterWest, Doug was a vice president at New Leaf Venture Partners where he spent three years focusing on biopharmaceutical, medical device, and diagnostics investments. He was involved with several investments, including Pearl Therapeutics, Interlace Medical (Acquired by Hologic), and Stromedix.
Prior to joining New Leaf, Doug was a project leader with The Boston Consulting Group where he was a member of the Health Care Practice Area and consulted for leading pharmaceutical and biotech companies.
Previously, he worked for Centocor (a J&J operating company) in the Global Biologic Strategic Marketing Group where he developed product strategies in new disease areas for Remicade.
Doug received an A.B. in economics with honors and distinction and a B.S. in biology with distinction from Stanford where he graduated Phi Beta Kappa. He has an M.D. from the University of Pennsylvania School of Medicine and an M.B.A. from Wharton where he graduated with honors as a Siebel Scholar and Palmer Scholar.
Senior VP, Corporate Development
Mar, 2009 - Current (over 7 years)
|Jul, 2015||Gynesonics||$43M / Private Equity||InterWest Partners|
|Feb, 2015||Invuity||$20M / Private Equity||InterWest Partners|
|Jan, 2015||Obalon Therapeutics||$20M / Series D||InterWest Partners|
|Jan, 2015||Sera Prognostics||$20M / Series B||InterWest Partners|
|Jul, 2014||Gynesonics||$28.45M / Debt Financing||InterWest Partners|
|Apr, 2014||Integrated Diagnostics||$30.25M / Series B||InterWest Partners|
|Sep, 2013||Integrated Diagnostics||$1.5M / Seed||InterWest Partners|
|Jul, 2012||Obalon Therapeutics||$16.5M / Series C (Lead)||InterWest Partners|
|Feb, 2012||Integrated Diagnostics||$10M / Series A (Lead)||InterWest Partners|
|Nov, 2011||Sera Prognostics||$19.3M / Series A (Lead)||InterWest Partners|
|Oct, 2009||Integrated Diagnostics||$30M / Series A (Lead)||InterWest Partners|
|Jun 28, 2016||Silicon Angle - Catching the increasing flow of data with an expanding ecosystem|
|Jun 22, 2016||Silicon Angle - Red Hat Summit 2016: How to watch all the interviews from theCUBE|
|May 26, 2016||Startup Ticker (Switzerland) - Lightbend Closes $20 Million in Series C Funding Led by Intel Capital|
|Nov 4, 2015||Information Week - Intel Primes The Internet Of Things Pump|
|Oct 26, 2015||Business Insider Australia - Intel and Oracle setup a secret team to take on cloud computing, IBM|
|Aug 28, 2015||Startup Daily - Houzz acquires GardenWeb; Coursera raises $49.5 million Series C round; Accodex raises $180,000 seed round - Startup Daily|
|Aug 25, 2015||ZD Net - Intel invests in BlueData, forges big data partnership|
|Aug 25, 2015||eWeek - Intel Partners with BlueData to Make Big Data Easier|